首页TWST • NASDAQ
add
Twist Bioscience Corp
昨日收盘价
$40.17
当日价格范围
$39.06 - $40.59
年度波幅
$30.32 - $60.90
市值
23.93亿 USD
平均交易量
118.92万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
收入 | 8871.30万 | 24.08% |
经营支出 | 7748.40万 | 2.03% |
净收入 | -3159.40万 | 26.54% |
净利润率 | -35.61 | 40.80% |
每股收益 | -0.53 | 29.33% |
息税折旧摊销前利润 | -2826.40万 | 27.17% |
有效税率 | -0.31% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.71亿 | -12.96% |
总资产 | 6.09亿 | -16.95% |
负债总额 | 1.53亿 | 6.91% |
权益总额 | 4.56亿 | — |
发行在外的股份 | 5965.11万 | — |
市净率 | 5.25 | — |
资产回报率 | -14.16% | — |
资本回报率 | -15.80% | — |
现金流
现金净变动
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
净收入 | -3159.40万 | 26.54% |
来自运营的现金 | -2142.80万 | 6.73% |
投资现金 | -153.60万 | -136.88% |
融资现金 | 1794.40万 | 1,318.19% |
现金净变动 | -507.30万 | 74.84% |
自由现金流 | -1125.45万 | -3.00% |
简介
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
CEO
成立时间
2013
员工数量
923
